With interest, we read the recent article by Castro et al, 1 and the corresponding editorial, 2 in Circulation Research, in which the authors find differential regulation of cGMP produced by particulate guanylyl cyclase (pGC) compared with that produced by soluble guanylyl cyclase (sGC). This work by experts in the field provides strong evidence in support of the paradigm of compartmentation of cGMP by phosphodiesterases within specific cellular microdomains. However, we are concerned that the use of atrial natriuretic peptide (ANP) by the investigators to "selectively" activate pGC neglects data showing that ANP also activates the sGC/NO pathway via natriuretic peptide receptor (NPR)-C. [3] [4] [5] When investigating the differences between sGC and pGC activation, it has been traditionally acceptable to differentiate the 2 pathways by "selectively" activating sGC with nitric oxide donors and "selectively" activating pGC using ANP. 6 However, with ANP able to bind to NPR-C with an affinity almost equal to that of NPR-A 7 and activate nitric oxide synthase via this receptor, 3 the distinct separation of pGC and sGC activation by the use of ANP needs to be urgently questioned.
